Virtual Town Hall

Helping Patients Navigate Regenerative Medicine and Cell-Based Therapies

Thurs, Mar 24, 2022 | 7:00pm – 7:45pm ET

The Promise of Regenerative Medicine and Cell Therapies

Peter Marks, MD, PhD, Rod Woodson, and James Kovach, MD, JD

The Need for New Therapies and Treatments: Insights from Pro Football Hall of Famer

Rod Woodson

11 Time Pro Bowler, Member, Hall of Fame

The Needs of Former Players: Insights on RMCTs

James Kovach, MD, JD

University of CA – Davis

The Current State of RMCTs
Insights for Patients

Peter Marks, MD, PhD

Food and Drug Administration

Actions Needed to Advance RMCTs: Why the Patient Guide is Important

Fred Sanfilippo, MD, PhD

Emory University

Key Takeaways for Patients

Peter Marks, MD, PhD, Rod Woodson, James Kovach, MD, JD, and Fred Sanfilippo, MD, PhD


Peter Marks, MD, PhD

Director, Center for Biologics Evaluation and Research, Food and Drug Administration

Rod Woodson

11 Time Pro Bowler, Super Bowl Champion, Member of the Pro Football Hall of Fame

James Kovach, MD, JD

Chief Innovation Officer, Aggie Square (UC-Davis Sacramento Innovation Center) and Director of Translational Entrepreneurship and Industry Research Relationships, University of California – Davis; Former NFL Player; Member, NFL Alumni Regenerative Medicine and Cell Therapy Advisory Committee

Fred Sanfilippo, MD, PhD

Professor, Pathology and Laboratory Medicine, School of Medicine, and Health Policy and Management, Rollins School of Public Health, Emory University; Director, Emory-Georgia Tech Healthcare Innovation Program; Former CEO, Woodruff Health Science Center, Emory University; Former CEO and Executive Dean, Ohio State Medical Center; Member, ACTN and NFLA Regenerative Medicine Advisory Commitees

Moderated By

Kyle Richardson

Vice Chair, Board of Directors, NFL Alumni, Advisory Board Member, Alliance for Cell Therapy Now

Janet Marchibroda

President, Alliance for Cell Therapy Now and Alliance for Cell Therapy Foundation , Executive Director and Vice President, NFL Alumni